AAAAAA
Results:
1-20
|
Results: 20
Authors:
Hackshaw, AK
Wald, NJ
Citation: Ak. Hackshaw et Nj. Wald, Assessment of the value of reporting partial screening results in prenatalscreening for Down syndrome, PRENAT DIAG, 21(9), 2001, pp. 737-740
Authors:
Hackshaw, AK
Wald, NJ
Citation: Ak. Hackshaw et Nj. Wald, Inaccurate estimation of risk in second trimester serum screening for Downsyndrome among women who have already had first trimester screening, PRENAT DIAG, 21(9), 2001, pp. 741-746
Authors:
Hackshaw, AK
Wald, NJ
George, LM
Citation: Ak. Hackshaw et al., Singleton versus duplicate assays in maternal serum screening - Reply, PRENAT DIAG, 21(10), 2001, pp. 895-896
Authors:
Hackshaw, AK
Wald, NJ
Citation: Ak. Hackshaw et Nj. Wald, Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers, PRENAT DIAG, 21(1), 2001, pp. 58-61
Authors:
Hackshaw, AK
Wald, NJ
George, LM
Citation: Ak. Hackshaw et al., Measuring serum markers once or twice in each assay in antenatal screeningfor Down syndrome and neural tube defects, PRENAT DIAG, 21(1), 2001, pp. 72-72
Authors:
Wald, NJ
Hackshaw, AK
Citation: Nj. Wald et Ak. Hackshaw, Folic acid and miscarriage: An unjustified link, AM J MED G, 98(2), 2001, pp. 204-204
Authors:
Geddes, JF
Hackshaw, AK
Vowles, GH
Nickols, CD
Whitwell, HL
Citation: Jf. Geddes et al., Neuropathology of inflicted head injury in children I. Patterns of brain damage, BRAIN, 124, 2001, pp. 1290-1298
Authors:
Geddes, JF
Vowles, GH
Hackshaw, AK
Nickols, CD
Scott, IS
Whitwell, HL
Citation: Jf. Geddes et al., Neuropathology of inflicted head injury in children II. Microscopic brain injury in infants, BRAIN, 124, 2001, pp. 1299-1306
Authors:
Wald, NJ
Hackshaw, AK
Citation: Nj. Wald et Ak. Hackshaw, Advances in antenatal screening for Down Syndrome, BEST P R CL, 14(4), 2000, pp. 563-580
Authors:
Wald, NJ
Hackshaw, AK
Cuckle, HS
Citation: Nj. Wald et al., Maternal serum alphafetoprotein screening for open neural tube defects: revised statistical parameters, BR J OBST G, 107(2), 2000, pp. 296-298
Authors:
Hackshaw, AK
Wald, NJ
Citation: Ak. Hackshaw et Nj. Wald, Revised distribution parameters for serum markers for trisomy 18, J MED SCREE, 7(4), 2000, pp. 215-215
Authors:
Wald, NJ
Hackshaw, AK
George, LM
Citation: Nj. Wald et al., Assay precision of serum alphafetoprotein in antenatal screening for neural tube defects and Down's syndrome (vol 7, pg 74, 2000), J MED SCREE, 7(3), 2000, pp. 168-168
Authors:
Wald, NJ
Hackshaw, AK
George, LM
Citation: Nj. Wald et al., Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome, J MED SCREE, 7(2), 2000, pp. 74-77
Authors:
Wald, NJ
Hackshaw, AK
Huttly, W
Citation: Nj. Wald et al., Screening for Down's syndrome - Serum screening programmes are effective and safe, BR MED J, 321(7263), 2000, pp. 763-764
Authors:
Wald, NJ
Hackshaw, AK
Watt, H
Citation: Nj. Wald et al., Nuchal translucency and trisomy 18, PRENAT DIAG, 20(4), 2000, pp. 353-354
Authors:
Hackshaw, AK
Wald, NJ
Michell, MJ
Field, S
Wilson, ARM
Citation: Ak. Hackshaw et al., An investigation into why two-view mammography is better than one-view in breast cancer screening, CLIN RADIOL, 55(6), 2000, pp. 454-458
Authors:
Wald, NJ
Hackshaw, AK
Frost, CD
Citation: Nj. Wald et al., When can a risk factor be used as a worthwhile screening test?, BR MED J, 319(7224), 1999, pp. 1562-1565
Authors:
Wald, NJ
Hackshaw, AK
Diamandis, EP
Melegos, DN
Citation: Nj. Wald et al., Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy, PRENAT DIAG, 19(7), 1999, pp. 674-676
Authors:
Wald, NJ
Hackshaw, AK
Watt, H
Citation: Nj. Wald et al., Nuchal translucency and trisomy 18, PRENAT DIAG, 19(10), 1999, pp. 995-996
Authors:
Wald, NJ
Watt, HC
Hackshaw, AK
Citation: Nj. Wald et al., Integrated screening for Down's syndrome based on tests performed during the first and second trimesters, N ENG J MED, 341(7), 1999, pp. 461-467
Risultati:
1-20
|